Yes. Gluten can enter a medication through its inactive ingredients (excipients), most often when a starch-based excipient is derived from wheat. A US drug label is not required to declare wheat or gluten, so a generic ingredient name like "starch" does not tell you the botanical source.
Gluten enters a medication chiefly through starch-based excipients, the inactive ingredients that bind, fill, and disintegrate a tablet. Wheat starch is the most direct route; pregelatinized starch and other starch derivatives can also be wheat derived depending on the manufacturer.
Excipients are not trivial. They commonly make up the large majority of a solid oral dose by weight, and the formulation work that selects them is rarely visible to the person taking the drug (Reker et al., Science Translational Medicine, 2019). Most starches used in medications are corn or potato derived and carry no gluten, but the source is a manufacturing choice that can differ between products and between manufacturers of the same drug.
The most direct route. Wheat starch is a recognized pharmaceutical excipient, and a product that uses it can carry gluten unless it has been processed to a gluten-free specification.
Starch that has been chemically or physically modified can still originate from wheat. The modified form does not, by itself, tell you the botanical source (Plogsted, 2015).
Not necessarily, and that is the problem. A label that simply reads "starch" can be corn, wheat, or potato derived depending on the manufacturer and even the production lot. The generic term does not identify the plant the starch came from.
Because the botanical source is not encoded in the ingredient name, you cannot determine gluten status by reading the label alone. Two products with an identical "starch" entry can differ in whether that starch carries gluten. The same is true for pregelatinized starch (Plogsted, 2015).
Treat a generic "starch" or "pregelatinized starch" entry as a source to confirm, not a conclusion. For a specific product, the botanical source has to be verified with the manufacturer.
Because the food allergen labeling law does not apply to medications. The Food Allergen Labeling and Consumer Protection Act (FALCPA) requires foods to declare major allergens such as wheat, but it does not cover prescription or over-the-counter drugs.
The practical consequence is that there is no "contains wheat" summary line on a medication and no standardized gluten statement. A drug must list its inactive ingredients, but it is not required to flag which of those ingredients carry an allergen or to identify the source of an ingredient like starch. The result is an information gap that the food aisle does not have.
Very small amounts can matter. People with celiac disease can react to traces of gluten, so a trace source in a daily medication can be clinically relevant even though the excipient is a minor part of the dose.
This is why a medication taken long term deserves attention even when the gluten contribution looks small on paper. A starch-based excipient in a once-daily tablet is an exposure that repeats every day. The clinical question is not only how much gluten a single dose carries, but whether the source can be confirmed and kept consistent over time.
For a specific product, confirm the botanical source of any starch or pregelatinized starch with the manufacturer. The label will not answer this, so a direct request to the manufacturer is the reliable path.
Plain-language references on the excipients clinicians ask about most. Each covers where the ingredient appears, who it affects, and what to verify with the manufacturer.
This page explains the general risk. To check the excipient profile of a specific medication against gluten and other exclusions, use the AllergenMaps clinical tool.